TELA Bio (TELA) Change in Receivables (2018 - 2026)
TELA Bio's quarterly Change in Receivables came in at -$593000.0 in Q1 2026, down 247.51% year-on-year from $402000.0 in Q1 2025, and up 36.37% quarter-over-quarter from -$932000.0 in Q4 2025.
TELA Bio has reported Change in Receivables for 9 years, with the latest figure at -$593000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 247.51% year-over-year to -$593000.0; the trailing twelve-month figure through Mar 2026 stood at -$885000.0 (down 195.16% YoY), and the FY2025 full-year result was $110000.0, down 85.56% from the prior year.
- Change in Receivables for Q1 2026 stood at -$593000.0, up from -$932000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.0 million in Q3 2024, with the low at -$983000.0 in Q4 2024.
- Average Change in Receivables over 5 years is $338705.9, with a median of $237000.0 recorded in 2023.
- Year-over-year, Change in Receivables surged 1200.0% in 2024 and sank 247.51% in 2026.
- Tracing TELA's Change in Receivables over 5 years: stood at $890000.0 in 2022, then surged by 80.0% to $1.6 million in 2023, then sank by 161.36% to -$983000.0 in 2024, then grew by 5.19% to -$932000.0 in 2025, then jumped by 36.37% to -$593000.0 in 2026.
- The last three Change in Receivables figures came in at -$593000.0 (Q1 2026), -$932000.0 (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -593,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -593,000.00 |
| Mar 31, 2026 | -593,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | -497,000.00 |
| Jun 30, 2024 | -497,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Dec 31, 2023 | 1.60 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 237,000.00 |
| Sep 30, 2023 | 237,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 18,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Dec 31, 2022 | 890,000.00 |
| Dec 31, 2022 | 890,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 1.03 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 85,000.00 |
| Mar 31, 2022 | 85,000.00 |
| Dec 31, 2021 | 657,000.00 |
| Dec 31, 2021 | 657,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 750,000.00 |
| Jun 30, 2021 | 750,000.00 |
| Mar 31, 2021 | 112,000.00 |
| Mar 31, 2021 | 112,000.00 |
| Dec 31, 2020 | 41,000.00 |
| Dec 31, 2020 | 41,000.00 |
| Sep 30, 2020 | 48,000.00 |
| Sep 30, 2020 | 48,000.00 |
| Jun 30, 2020 | 543,000.00 |
| Jun 30, 2020 | 543,000.00 |
| Mar 31, 2020 | -781,000.00 |
| Mar 31, 2020 | -781,000.00 |
| Dec 31, 2019 | 545,000.00 |
| Dec 31, 2019 | 545,000.00 |
| Sep 30, 2019 | 384,000.00 |
| Sep 30, 2019 | 384,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Jun 30, 2019 | 20,000.00 |
| Mar 31, 2019 | 579,000.00 |
| Mar 31, 2019 | 579,000.00 |
| Dec 31, 2018 | 66,000.00 |
| Dec 31, 2018 | 66,000.00 |